Beijing GoBroad Hospital Management Co., Ltd. (GoBroad Healthcare Group) is a modern private healthcare network in China focused on the development of research hospitals and the treatment of complex oncological and hematological diseases. Established in 2017, the Group specializes in high-tech medical care and the implementation of innovative treatment approaches.
Currently, GoBroad operates several specialized hospitals and clinics in Beijing, Shanghai, and Guangzhou, with a total capacity of approximately 1,500 beds. Its core areas of expertise include the treatment of hematological malignancies, solid tumors, and central nervous system cancers using advanced targeted therapy, immunotherapy, and CAR-T cell therapy.The Group integrates clinical practice, scientific research, and participation in international clinical trials, creating a comprehensive “research – development – clinical application” model and holding a prominent position in China’s medical innovation sector.
